Randomized controlled trial of the Tobacco Tactics website versus 1-800-QUIT-NOW telephone line among Operating Engineers by Choi, Seung H et al.
MEETING ABSTRACT Open Access
Randomized controlled trial of the Tobacco
Tactics website versus 1-800-QUIT-NOW
telephone line among Operating Engineers
Seung Hee Choi1, Andrea H Waltje1, David L Ronis1, Devon Noonan2, Oisaeng Hong3, Caroline Richardson4,5,
John D Meeker6, Sonia A Duffy1,4,7,8*
From 11th Annual Conference of the International Society for the Prevention of Tobacco Induced Diseases
(ISPTID)
Athens, Greece. 9-11 December 2013
Background
The purpose of this study was to evaluate the efficacy
and usage of the Tobacco Tactics website compared to
the 1-800-QUIT-NOW telephone line among Operating
Engineers (heavy equipment operators).
Materials and methods
Smokers attending workplace safety training groups were
randomized to either the Tobacco Tactics website with
nurse phone counseling and access to nicotine replace-
ment therapy (NRT) or to the 1-800-QUIT-NOW tele-
phone line which provided an equal number of phone
calls and NRT. Participating Operating Engineers com-
pleted a baseline survey as well as mailed surveys at
30-days and 6-months. Urinary cotinine tests were used to
verify 6-month smoking status. The outcomes were com-
pared using c2 tests, t-tests, mixed models, generalized
mixed models, and logistic regression models.
Results
Compared to participants in the 1-800-QUIT-NOW
group, significantly more of those in the Tobacco Tactics
website group participated in the intervention, received
phone calls and found the intervention helpful (p < 0.05).
Seventy percent of the website group received NRT com-
pared to 5.1% of the quitline group (p < 0.001). At 30-day
follow-up, the Tobacco Tactics website group showed sig-
nificantly higher quit rates (26.9%) than the 1-800-QUIT-
NOW group (7.7%) (p < 0.05), but this difference was no
longer significant at 6-month follow-up. There were signif-
icantly more positive changes in harm reduction measures
(quit attempts, number of cigarettes smoked per day, and
nicotine dependence) at both 30-day and 6-month follow-
up in the Tobacco Tactics website group compared to the
1-800-QUIT-NOW group (p < 0.05).
Conclusions
The Tobacco Tactics website showed higher efficacy and
reach than the 1-800-QUIT-NOW intervention. Longer
counseling sessions may be needed to improve 6-month
cessation rates. This intervention has the potential to reduce
morbidity and mortality among Operating Engineers.
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